Aakaar Medical Technologies Limited, a Pune-based medical device manufacturer, is all set to launch its Initial Public Offering (IPO) on June 27, 2025. The issue comprises a 100% fresh equity offering worth ₹48 crore and will be listed on the NSE SME platform.

Aakaar Medical Technologies IPO Details

About Aakaar Medical Technologies Limited

Incorporated in 2008, Aakaar Medical Technologies Ltd is involved in designing, manufacturing, and marketing of medical consumables and disposable products under the “Aakaar” brand.

Key Product Categories:

• Disposable syringes

• Surgical gloves

• IV sets

• Blood transfusion sets

• Urine bags

• Surgical gowns and drapes

Their products are used extensively in hospitals, pathology labs, and clinics, and meet both domestic and export demand, including supplies to government healthcare procurement agencies.

Manufacturing Capacity:
Operates a modern facility in Pune with advanced assembly lines, sterilisation chambers, and clean room environments conforming to ISO 13485:2016 and CE certification.

Use of IPO Proceeds

The company plans to use the IPO funds for:

1. Setting up a new sterile medical disposables production unit

2. Expansion of manufacturing facilities

3. Working capital requirements

4. General corporate purposes

5. Public issue expenses

Company Financials

Key Ratios (FY24):

• EPS (Pre-Issue): ₹7.11

• EPS (Post-Issue): ₹5.18

• P/E Ratio (Post-Issue): 19.11x

• ROE: 19.74%

• ROCE: 25.65%

• Debt-to-Equity: 0.38

These figures suggest a steadily growing and profitable business model.

Promoters and Management

• Mr. Rajeev Joshi – Chairman and Managing Director, with over 25 years of experience in medical devices manufacturing

• Mrs. Sonali Joshi – Executive Director, overseeing administration and procurement

The promoters hold over 95% pre-issue stake and have established long-term ties with major hospital networks.

Industry Overview

India’s medical device market is one of the fastest growing globally, expected to cross $50 billion by 2030, led by:

• Government support under PLI scheme for medical device manufacturing

• Increased demand for disposable and infection-control products post-COVID

• Growing hospital and healthcare infrastructure in Tier-II & Tier-III cities

• Domestic manufacturing replacing imported consumables for cost efficiency

Aakaar stands to benefit from this trend as an established local player with certified production.

Grey Market Premium (GMP)

As of June 19, 2025, GMP for Aakaar Medical IPO is ₹7–₹9, implying a listing gain of ~7–9%. GMP fluctuates with sentiment and demand but gives a rough sense of interest from the grey market.

IPO Strengths

• Wide product portfolio catering to essential healthcare supplies

• Certified production quality (ISO & CE) with compliance advantage

• Strong financial performance with rising margins and profits

• Healthy order book from both private and public sector buyers

IPO Risks

• Faces competition from larger players like Poly Medicure, Hindustan Syringes

• Dependency on few products for majority revenue

• Regulatory risks related to medical compliance and certifications

• SME IPOs often face post-listing liquidity issues

Peer Comparison

Disclaimer:
This article is for educational and informational purposes only and does not constitute financial advice. Investment decisions should be based on individual risk tolerance and consultation with SEBI-registered advisors. Market conditions are volatile and subject to change. Neither the author nor the platform is responsible for losses arising from use of this information.

The Upcoming IPOs in this week and coming weeks are Suntech Infra Solutions, Shri Hare-Krishna Sponge Iron, Icon Facilitators, Ace Alpha Tech, Aakaar Medical Technologies, Safe Enterprises Retail Fixtures, Globe Civil Projects, Sambhav Steel Tubes, Ellenbarrie Indutrial Gases, Kalpataru, HDB Financials, AJC Jewel, Mayasheel Ventures.

The Current active IPO are  ArisInfra Solutions, Influx Healthtech, Eppeltone Engineers.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analys